Liposomal Doxorubicin Market to hit US$ 2.05 Billion by 2030 | Exclusive Report by Growth Plus Reports
October 27, 2022 07:05 ET
|
Growth Plus Reports
Pune, Oct. 27, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Liposomal Doxorubicin Market by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), by...
Rising Incidence of Cancer to Drive Doxorubicin Market at CAGR of 5.3% through 2026: Fact.MR Research
May 04, 2022 19:00 ET
|
FACT.MR
United States, Rockville MD, May 04, 2022 (GLOBE NEWSWIRE) -- According to a recently published Fact.MR report, the global Doxorubicin Market is projected to grow at a compound annual rate (CAGR) of...
Liposomal Doxorubicin Market in U.S. to Surpass US$ 192.9 Million by 2027, Says Coherent Market Insights (CMI)
July 09, 2021 08:40 ET
|
CMI
SEATTLE, July 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. liposomal doxorubicin market is estimated to be valued at US$ 140.0 Million in 2020 and is expected to...